Study finds digital treatment for osteoarthritis is superior to traditional routine care

The steadily increasing prevalence and high costs of treating chronic joint pain worldwide poses a challenge for healthcare systems and healthcare payers. New research published today in JAMA Network Open shows the effectiveness of a digital healthcare treatment with the potential to save insurance companies and their patients the costs and risks of joint surgeries—a finding that is especially promising as more patients turn to telemedicine as a safe treatment option amid the COVID-19 pandemic.

A new randomized controlled trial (RCT) conducted by the University of Nottingham using Joint Academy’s clinical evidence-based digital treatment for chronic joint pain is the first to find clinically important improvements of treating knee osteoarthritis digitally compared to traditional treatment. Patients receiving digital treatment reduced their pain by 41 percent, while patients receiving traditional care only experienced a 6 percent decrease.

A total of 105 people, who were 45 years or older with a diagnosis of knee osteoarthritis, participated in the study. They were allocated at random to two groups. One was treated digitally and the other self-managed their symptoms according to guidelines. Patients in the digital treatment were connected with licensed physical therapists via a smartphone application where they received education and daily exercises. In the other group, patients continued their traditional self-management program and visited their general practitioner when needed.

“The results of the study really show how much can be gained by treating chronic knee pain digitally, and this will help reduce the burden on the healthcare system, especially when we are going through the COVID-19 pandemic where services are already stretched. We hope this study allows health policy-makers to consider the potential in digital alternatives when it comes to treating knee arthritis”, says Sameer Akram Gohir, physical therapist and researcher at the University of Nottingham.

Osteoarthritis is one of the world’s fastest growing and most costly chronic diseases. According to the Centers for Disease Control, more than 32 million U.S. adults are affected. It is also among the most expensive conditions to treat when joint replacement surgery is required. For the millions who suffer with the daily pain and stiffness of osteoarthritis, treatments to slow the progression of the disease are limited. The recommended first-line treatment, consisting of information, exercise and weight control when needed, is underutilized.

“The study shows the positive impact digital treatment has on the osteoarthritis burden for both patients and healthcare systems. Besides the beneficial outcomes in pain and physical function, the advantages of digital treatment include lower costs as well as making care more easily accessible for those living in rural areas far from the nearest physical therapist,” Dahlberg concludes.

Joint Academy connects patients with licensed physical therapists through telemedicine, making it a safe treatment option during the COVID-19 pandemic. The treatment is now available under certain health plans in the United States and seeking to expand to become available to more providers and patients in 2021.

The original article can be found at: MedicalXpress